v3.26.1
Material Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Material Accounting Policies [Abstract]  
Schedule of Share Capital Consisting Solely of Ordinary Shares

The Group’s subsidiaries as at December 31, 2025 are set out below. Unless otherwise stated, such subsidiaries have share capital consisting solely of ordinary shares that are held directly by the Company, and the proportion of ownership interests held equals the voting rights held by the Company.

 

   Place of business/
country of
  Functional  Ownership
interest held by
the Company
    
Name  incorporation  currency  2025   2024   Principal activities
InflaRx GmbH  Jena and Munich, Germany  EUR   100%   100%  Operating subsidiary, R&D, holder of all IP
InflaRx Pharmaceuticals, Inc.  Ann Arbor, MI, United States  USD   100%   100%  Operating subsidiary, R&D, US commercialization